EP 0934274 A1 19990811 - SUBSTITUTED PYRIDINES AND BIPHENYLS AS ANTI-HYPERCHOLESTERINEMIC, ANTI-HYPERLIPOPROTEINEMIC AND ANTI-HYPERGLYCEMIC AGENTS
Title (en)
SUBSTITUTED PYRIDINES AND BIPHENYLS AS ANTI-HYPERCHOLESTERINEMIC, ANTI-HYPERLIPOPROTEINEMIC AND ANTI-HYPERGLYCEMIC AGENTS
Title (de)
SUBSTITUIERTE PYRIDINE UND BIPHENYLE ALS ANTI-HYPERCHOLESERINÄMISCHE, ANTI-HYPERLIPOPROTEINÄMISCHE UND ANTI-HYPERGLYZÄMISCHE MITTEL
Title (fr)
PYRIDINES ET DIPHENYLES SUBSTITUES UTILISES COMME AGENTS ANTIHYPOCHOLESTEROLEMIQUES, ET ANTIHYPERLIPOPROTEINEMIQUES ET ANTIHYPERGLYCEMIQUES
Publication
Application
Priority
- US 9713248 W 19970729
- US 69011196 A 19960731
Abstract (en)
[origin: WO9804528A2] Substituted pyridines of formula (IA) are produced by reaction of suitably substituted pyridylaldehydes with Grignard or Witting reagents, and the resulting products are appropriately reduced. The pyridines of formula (IA) are suitable as active compounds in pharmaceutical products, particularly in pharmaceutical products for the inhibition of cholesterol ester transfer proteins. 3-Heteroalkyl-aryl-substituted pyridines of formula (IB) are produced from pyridines which are correspondingly protected at the hydroxy group and correspondingly substituted. The compounds of formula (IB) according to the invention are suitable as active compounds in pharmaceutical products, particularly pharmaceutical products for the treatment of hyperlipoproteinemia. Substituted pyridines and benzenes of formula (IC) are produced by procedures disclosed herein, and are useful as active ingredients in pharmaceutical products, particularly pharmaceutical products for inhibition of the glucagon receptor, leading to treatment of glucagon-mediated conditions such as diabetes.
IPC 1-7
IPC 8 full level
C07C 33/24 (2006.01); A61K 31/045 (2006.01); A61K 31/055 (2006.01); A61K 31/075 (2006.01); A61K 31/10 (2006.01); A61K 31/425 (2006.01); A61K 31/426 (2006.01); A61K 31/435 (2006.01); A61K 31/44 (2006.01); A61K 31/4409 (2006.01); A61K 31/4427 (2006.01); A61K 31/443 (2006.01); A61K 31/4436 (2006.01); A61K 31/4439 (2006.01); A61K 31/451 (2006.01); A61K 31/4545 (2006.01); A61K 31/47 (2006.01); A61K 31/496 (2006.01); A61K 31/5377 (2006.01); A61P 3/10 (2006.01); C07C 33/46 (2006.01); C07C 39/12 (2006.01); C07C 39/205 (2006.01); C07C 39/367 (2006.01); C07C 43/178 (2006.01); C07C 323/16 (2006.01); C07C 323/20 (2006.01); C07D 213/24 (2006.01); C07D 213/30 (2006.01); C07D 213/32 (2006.01); C07D 213/34 (2006.01); C07D 213/36 (2006.01); C07D 213/38 (2006.01); C07D 213/50 (2006.01); C07D 213/55 (2006.01); C07D 213/64 (2006.01); C07D 213/70 (2006.01); C07D 213/74 (2006.01); C07D 213/80 (2006.01); C07D 215/14 (2006.01); C07D 221/04 (2006.01); C07D 275/02 (2006.01); C07D 277/22 (2006.01); C07D 401/06 (2006.01); C07D 401/12 (2006.01); C07D 403/04 (2006.01); C07D 403/06 (2006.01); C07D 405/04 (2006.01); C07D 405/06 (2006.01); C07D 405/12 (2006.01); C07D 407/04 (2006.01); C07D 409/04 (2006.01); C07D 411/12 (2006.01); C07D 413/04 (2006.01); C07D 413/06 (2006.01); C07D 413/12 (2006.01); C07D 417/04 (2006.01); C07D 417/12 (2006.01); C07D 419/04 (2006.01); C07D 487/04 (2006.01); C07D 521/00 (2006.01); C07F 7/18 (2006.01); C07D 211/26 (2006.01)
CPC (source: EP KR US)
A61P 3/06 (2017.12 - EP); A61P 3/10 (2017.12 - EP); C07D 213/24 (2013.01 - KR); C07D 213/30 (2013.01 - EP US); C07D 213/32 (2013.01 - EP US); C07D 213/34 (2013.01 - EP US); C07D 213/38 (2013.01 - EP US); C07D 213/50 (2013.01 - EP US); C07D 213/55 (2013.01 - EP US); C07D 213/64 (2013.01 - EP US); C07D 213/70 (2013.01 - EP US); C07D 213/74 (2013.01 - EP US); C07D 213/80 (2013.01 - EP US); C07D 215/14 (2013.01 - EP US); C07D 221/04 (2013.01 - EP US); C07D 231/12 (2013.01 - EP US); C07D 233/56 (2013.01 - EP US); C07D 249/08 (2013.01 - EP US); C07D 401/06 (2013.01 - EP US); C07D 401/12 (2013.01 - EP US); C07D 405/04 (2013.01 - EP US); C07D 405/06 (2013.01 - EP US); C07D 405/12 (2013.01 - EP US); C07D 409/04 (2013.01 - EP US); C07D 411/12 (2013.01 - EP US); C07D 413/06 (2013.01 - EP US); C07D 413/12 (2013.01 - EP US); C07D 417/12 (2013.01 - EP US); C07D 487/04 (2013.01 - EP US); C07F 7/1804 (2013.01 - EP US)
Designated contracting state (EPC)
AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
DOCDB simple family (publication)
WO 9804528 A2 19980205; WO 9804528 A3 19991111; AR 008789 A1 20000223; AR 037300 A2 20041103; AU 3897197 A 19980220; BG 103200 A 19991130; BR 9710637 A 20001031; CA 2262434 A1 19980205; CN 1239474 A 19991222; CO 4900061 A1 20000327; CZ 30899 A3 19990512; EP 0934274 A1 19990811; HR P970425 A2 19980831; HU P0100324 A2 20010528; HU P0100324 A3 20010628; ID 19422 A 19980709; IL 128251 A0 19991130; JP 2001512416 A 20010821; KR 20000029723 A 20000525; NO 314143 B1 20030203; NO 990399 D0 19990128; NO 990399 L 19990329; NZ 333951 A 20000929; PL 333465 A1 19991220; RU 2195443 C2 20021227; TR 199900163 T2 19990421; TR 199902325 T2 20000221; TR 199902326 T2 20000522; TW 520360 B 20030211; US 6218431 B1 20010417; ZA 976730 B 19990729
DOCDB simple family (application)
US 9713248 W 19970729; AR P020104321 A 20021111; AR P970103411 A 19970728; AU 3897197 A 19970729; BG 10320099 A 19990223; BR 9710637 A 19970729; CA 2262434 A 19970729; CN 97198258 A 19970729; CO 97043316 A 19970729; CZ 30899 A 19970729; EP 97936259 A 19970729; HR P970425 A 19970729; HU P0100324 A 19970729; ID 972662 A 19970731; IL 12825197 A 19970729; JP 50906898 A 19970729; KR 19997000826 A 19990130; NO 990399 A 19990128; NZ 33395197 A 19970729; PL 33346597 A 19970729; RU 99104527 A 19970729; TR 9900163 T 19970729; TR 9902325 T 19970729; TR 9902326 T 19970729; TW 86110851 A 19970729; US 90411997 A 19970731; ZA 976730 A 19970729